Japan's Topix index fell to 1%.The three major stock indexes opened lower and went lower. The Shenzhen Stock Exchange Index and the Growth Enterprise Market Index all fell more than 1%, and the Shanghai Composite Index fell 0.88%.The net outflow of the main market exceeded 10 billion.
The change in the concept of ice and snow industry has boosted the daily limit of iceberg cold and snowman shares, while the change in the concept of ice and snow industry has boosted the daily limit of iceberg cold and snow, snowman shares and Rhine Sports, and Sanfu Outdoor, Dalian Shengya, Changbai Mountain and Yuanlongyatu have followed suit.Shunkong developed 50 million yuan to set up an industrial investment company. According to the enterprise survey APP, recently, Guangdong Shunkong Qingxun Industrial Investment Co., Ltd. was established with Liang Weifeng as the legal representative and a registered capital of 50 million yuan. Its business scope includes: sales of eco-environmental materials; Sales of building materials; Sales of new membrane materials; Sales of synthetic materials, etc. Enterprise investigation shows that the company is wholly owned by Shunkong Development.In the exchange market, the national debt rose the most, with "National Debt 2404" rising more than 4%, "National Debt 23", "Special Country 24 03" and "Special Country 24 01" rising nearly 1%.
Solar energy and other new companies have set up photovoltaic power generation equipment business. The enterprise search APP shows that recently, China Energy Saving Ledebao Solar Technology (Delingha) Co., Ltd. was established, with Du Hu as the legal representative and a registered capital of 1 million yuan. Its business scope includes: sales of solar thermal utilization equipment; Lease of photovoltaic power generation equipment; Ecological restoration and ecological protection services, etc. Enterprise investigation shows that the company is jointly owned by China Energy Saving Solar Technology Co., Ltd. and Qinghai Laidebao New Materials Co., Ltd., a wholly-owned subsidiary of solar energy.Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.The Nikkei 225 index fell to 1%.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13